Use of mannuronic diacid composition in treatment of diabetes

Invention Grant

US11406652B2 Use of mannuronic diacid composition in treatment of diabetes 有权

Patent Title: Use of mannuronic diacid composition in treatment of diabetes
Application No.: US17256889

Application Date: 2019-06-28
Publication No.: US11406652B2

Publication Date: 2022-08-09
Inventor: Meiyu Geng , Xianliang Xin , Zhenqing Zhang , Jian Ding
Applicant: GREEN VALLEY (SHANGHAI) PHARMACEUTICAL CO., LTD. , SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
Applicant Address: CN Shanghai; CN Shanghai
Assignee: GREEN VALLEY (SHANGHAI) PHARMACEUTICAL CO., LTD.,SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
Current Assignee: GREEN VALLEY (SHANGHAI) PHARMACEUTICAL CO., LTD.,SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
Current Assignee Address: CN Shanghai; CN Shanghai
Agency: McCarter & English, LLP
Agent Wei Song; Sudheer Chava
Priority: CN201810721304.5 20180629
International Application: PCT/CN2019/093822 WO 20190628
International Announcement: WO2020/001644 WO 20200102
Main IPC: A61P3/10
IPC: A61P3/10 ; A61K31/715 ; A61K31/7032 ; A61K31/702 ; A61K31/7012 ; A61K31/7016

Abstract:

The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of diabetes.

Public/Granted literature

Information query

Espacenet

IPC分类: